An anti-inflamatory nonsteroidal drug (indomathacin) was employed in a group of 40 migrainous patients. The drug was utilized just during the attacks. Positive results were obtained in 72% of the cases. Twenty-six patients had already utilized the ergotamine tartrate on a large scale without improvement.